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Introduction: Epstein-barr virus (EBV) is widely distributed with 90-95% of adults are 
seropositive. This virus is spread by intimate contact between susceptible persons and 
asymptomatic shedders. EBV can be the causative agent of some B and T cell 
lymphomas, Hodgkin disease, nasopharyngeal carcinoma and also as one of the cofactor 
in the development of many types of carcinomas including breast cancer. The role of 
Epstein-barr virus (EBV) in breast cancer is not well documented and reports are very 
controversial. On the other hand, current belief holds that chromosomal deficiency and 
translocation, deletion, insertion and point mutation in the p53 tumor suppressor gene 
(p53 gene) which plays an important role in the regulation of cell growth, differentiation 
and DNA repair can play a role. Abnormal cell proliferation is thought to be induced by 
p53 gene deficiency. In human carcinogenesis, p53 mutations are reported in esophageal 
carcinoma with documented changes in protein expression. There is also evidence that 
mechanisms other than point mutation may result in p53 protein accumulation and 
inactivation in a subset of breast cancer. Epidemiologic studies have implicated several 
lifestyle risk factors: tobacco exposure, alcohol consumption, diet, obesity in esophageal 
carcinoma. However, the clinical significance and potential applications of these 
observations in breast cancer remains unclear. 
Materials and Methods: A total of 159 archival formalin fixed paraffin-embedded 
(FFPE) breast tissues were collected from Pathology Department, Hospital Tuanku 
Ja'afar, Seremban and were screened for (i) EBV, (\\)p53 gene and (iii) p53 protein. For 
EBV, Epstein-Barr virus encoded RNA (EBER1) transcripts was screened by in situ 
hybridization (ISH) for nuclear staining and further analyzed by Polymerase Chain 
Reaction (PCR) for EBER 1 gene. For p53 protein, a commercial kit (Real TM En Vision 
Detection System ,Dako, Denmark) by immunohistochemistry (IHC) method was used. 
Samples that were p53 protein positive were further examined by amplification of exons 
5 to 8 of p53 gene using specific primers. For epidemiology studies, the following 
clinical information were taken from patients' histopathology laboratory report: patients' 
age, tumor grade status and several other risk factor profiles (Form Perub. J.P. 06). A 
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modified version of the Bloom and Richardson grading system was used to determine the 
malignancy grade of tumour samples (based on three tumour features: tubule formation, 
nuclear pleomorphism and mitotic count). SPSS version 17 was used for statistical 
analyses. Frequency and chi-square tests were used to explore the association between 
p53 protein, age, racial differences and tumour grade, the relatedness between EBV and 
breast cancer, EBV positivity and histological grade. 
Results: By ISH, EBV was detected in 83/159 (52.2%) breast cancer samples and 
12/159 (7.55%) in normal tissues with an intense blue-black nuclear staining of EBERl 
transcripts. EBV was found to have a significant relationship with breast cancer 
(p=0.000). The presence of EBV genome in these samples were confirmed by PCR. 
Altogether with both ISH and PCR for EBER 1 gene, 101/159 (63.52%) samples were 
positive for EBERl gene. Two PCR positive samples were sent for sequencing, and the 
sequences were BLAST, aligned and were analyzed phylogenetically. Both samples were 
found to be 100% similar to the EBV EBERl gene sequences already deposited in the 
GenBank (accession numbers AB065135, FN545286, EF187853 and DQ883818) and 
later were used as in-house positive controls for EBERl gene. 
For p53 protein, by IHC method, a positive reaction was determined when intensely 
stained nuclei were seen in more than 10% of the total cancer cells with 1+ representing 
10-50% staining and 2+ representing >50% staining of the tumor cells present in the 
sections. Based on these criteria, IHC results were classified into positive and negative. 
The scoring of p53 protein expressions were performed by two pathologists 
independently (from Hospital Tuanku Jaafar ,Seremban) and blinded to any 
clinicopathological information. Nuclear p53 protein correlation with epidemiological 
risk factors and histological grade found that 39/159 (24.5%) were overexpressed and 
significantly present in breast tissue samples (p=0.002) and histological grade (p = 
0.000). In the Malay and Indian females, there is a significant correlation with 
histological grade and p53 protein overexpression (p= 0.002) with high frequency of 
cases between 36-45 years and 46-55 years age group. Among the Chinese women, p53 
protein overexpression is in the 46-55 years age group (8.1%) and above 56 years old 
(18.9%). With regard to p53 protein overexpression positivity and tumor grade, this is 
highest in tumor grade 3 (42.0%) in all the races. 
For p53 gene analysis, detail analysis of two samples found that exons 5 and 8 exhibited 
point mutation at nucleotide number 64 (G to C) and at nucleotide number 76 (A to G) in 
another sample. These mutations resulted in the over-production of a mutated protein that 
accumulates in the cells. 
Conclusions: This study confirmed that EBV can be detected in both breast cancer 
tissues and normal breast tissues. There is a point mutation of p53 gene that results in 
accumulation of p53 proteins. p53 protein overexpression is detectable in breast cancer 
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